The goals of Core D (Neuropathology) are to perform postmortem neuropathologic evaluations of participants in the Udall Center. In addition, Core D will provide neuropathologic support to research projects, in particular tau biochemical support and immunohistochemistry for Project 2 , as well as tissue processing and histology for Project 3. Core D will also assist Project 3 with electron microscopic studies. To accomplish these objectives, the specific aims of Core D will:
Specific Aim 1. Perform standardized diagnostic neuropathologic evaluations and data collection on all brains harvested locally or sent to the Udall Center by referring physicians, with particular focus on cases followed by Core B. This will include a) immunostaining of cortical, hippocampal and basal forebrain sections for a-synuclein to record density of Lewy bodies in multiple cortical regions;b) characterizing non-Lewy body Parkinsonian degenerative disorders with immunocytochemistry, including antibodies to tau, TDP-43, ubiquitin, FUS, a-internexin and aB-crystallin, recording estimates of neuronal and glial lesions in neocortex, hippocampus, basal ganglia, thalamus, subthalamic nucleus, midbrain, pons, medulla and cerebellar dentate nucleus for cases with tauopathy;c) assessing Alzheimer type pathology with counts of senile plaques and neurofibrillary tangles in multiple cortical and subcortical areas with thioflavin-S fluorescent microscopy, and assign a Braak neurofibrillary tangle stage on all cases;and d) using validated neuropathologic research criteria for those disorders for which such criteria have been established and "best clinical practice" for uncommon disorders for which research criteria do not yet exist.
Specific Aim 2. Provide frozen human brain samples or DNA to investigators in the Udall Center, particulady Projects 1 and 2, as well as to qualified investigators at other research institutions.
Specific Aim 3. Assist Projects 2 with biochemical studies of tau protein in human brain samples.
Specific Aim 4. Assist Project 3 with neuropathologic characterization of mouse models subjected to drug treatments and with electron microscopic support to evaluate effects of drugs on tau and a-synuclein fibrillization.

Public Health Relevance

The "gold standard" for diagnosis of neurodegenerative disorders, such as Parkinson disease (PD), is neuropathology, which is the medical specialty that uses microscopic evaluation of tissue changes to arrive at a diagnosis. Accurate diagnosis is critical to finding genes and other factors that cause PD, which are the first steps in the process of finding a cure for PD and related disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS072187-03
Application #
8440421
Study Section
Special Emphasis Panel (ZNS1-SRB-J (01))
Project Start
Project End
Budget Start
2012-09-24
Budget End
2013-06-30
Support Year
3
Fiscal Year
2012
Total Cost
$160,585
Indirect Cost
$57,975
Name
Mayo Clinic Jacksonville
Department
Type
DUNS #
153223151
City
Jacksonville
State
FL
Country
United States
Zip Code
32224
Lorenzo-Betancor, Oswaldo; Wszolek, Zbigniew K; Ross, Owen A (2016) Rare variants in MC1R/TUBB3 exon 1 are not associated with Parkinson's disease. Ann Neurol 79:331
Kovacs, Gabor G; Ferrer, Isidro; Grinberg, Lea T et al. (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87-102
Tacik, Pawel; Sanchez-Contreras, Monica; Rademakers, Rosa et al. (2016) Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories. Neurodegener Dis 16:12-21
Tipton, Philip W; Konno, Takuya; Broderick, Daniel F et al. (2016) Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases. Parkinsonism Relat Disord 32:31-35
Williams, Kelly L; Topp, Simon; Yang, Shu et al. (2016) CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun 7:11253
Ogaki, Kotaro; Koga, Shunsuke; Aoki, Naoya et al. (2016) Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review. Neuropathology 36:64-76
Tacik, Pawel; Curry, Sadie; Fujioka, Shinsuke et al. (2016) Cancer in Parkinson's disease. Parkinsonism Relat Disord 31:28-33
Jiang, Peizhou; Gan, Ming; Yen, Shu-Hui et al. (2016) Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons. Acta Neuropathol 132:77-91
Walton, Ronald L; Soto-Ortolaza, Alexandra I; Murray, Melissa E et al. (2016) TREM2 p.R47H substitution is not associated with dementia with Lewy bodies. Neurol Genet 2:e85
Soto-Ortolaza, Alexandra I; Ross, Owen A (2016) Genetic susceptibility variants in parkinsonism. Parkinsonism Relat Disord 22 Suppl 1:S7-11

Showing the most recent 10 out of 218 publications